Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2001-01-12
2007-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will build upon previous brain imaging studies of healthy volunteers and children who have AD/HD. This study will use diffusion tensor magnetic resonance imaging (DT-MRI) to visualize and measure certain parts of the brains of identical twin pairs in which one twin has AD/HD, combined type.
Participants in this study will be screened with questionnaires and interviews, psychometric testing, and a physical examination. Participants' medical and educational records may be reviewed. Participants will undergo an MRI scan of the brain. Prior to the MRI, participants will have a training session in a simulated MRI scanner to learn how to lie still during MRI scanning. Participants may be asked to return for a follow-up scan in about 2 years.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cerebellar Loops and Attention Deficit Hyperactivity Disorder (ADHD)
NCT00684931
New Ways of Doing Magnetic Resonance Imaging in Children and Adults
NCT04643015
Study of New Magnetic Resonance Imaging Methods of the Brain
NCT00004577
Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder
NCT00029120
Magnetic Resonance Imaging of Brain Development in Autism
NCT00449566
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Subjects for pilot data collection will initially be up to 10 unscreened adult volunteers who have been previously studied on the 1.5-Tesla Signa scanner. Subjects will be required to provide informed consent, and to not have any medical exclusions as noted in the consent form and below, particularly metallic objects and/or pregnancy. Once procedures are optimized, up to 10 pediatric subjects will be studied. These pilot subjects will be derived from the normal control pool of subjects who have been previously studied on the 1.5-Tesla Signa scanner. Informed consent and signed assent will be required, with the same exclusions.
MONOZYGOTIC TWINS:
Subjects must be monozygotic twins (MZ) as confirmed by twin-similarity questionnaire and by molecular cheek swab testing by polymerase chain reaction short tandem repeat multiplex loci sets to find differences in the DNA types of the two co-twins. The primary test set includes nine to fourteen unlinked loci with a combined matching probability for siblings p less than .0001. Cases yielding a probability of twinship less than 0.99 are tested further to a total of 21 loci. Subjects may also be requested to participate in an associated genetic protocol (96-M-0060).
ADHD PROBANDS:
Monozygotic twin.
Aged 6 - 21 years.
DSM-IV diagnosis of ADHD (inattentive, hyperactive-impulsive and combined types).
Age adjusted dimensional ratings (Conners Rating Scales-Revised, or Strengths and Weaknesses of ADHD and Normal Behavior (SWAN)) hyperactivity/impulsivity greater than or equal to 95th percentile in affected twin.
Consent and assent obtained in writing.
NORMAL PEDIATRIC VOLUNTEERS:
Except for pilot subjects (up to 10 subjects), must be monozygotic twin.
Same age-range as probands.
Parent and teacher ratings within one SD of population means on ADHD/hyperactivity factors.
Consent and assent obtained in writing.
Exclusion Criteria
Presence of other psychiatric disorders that can produce symptoms similar to ADHD (e.g., major depression, bipolar disorder, severe anxiety disorders, pervasive developmental disorders, psychotic disorders, post-traumatic stress disorder).
Presence of neuropsychiatric conditions that may confound evaluation of ADHD (e.g., Tourette's syndrome, obsessive-compulsive disorder, or PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcus).
Presence of metal objects, pregnancy, or inability to provide a specimen of urine or blood to rule out pregnancy in females over age 12.
Presence of alcohol and/or other substance abuse.
NORMAL PEDIATRIC VOLUNTEERS:
Presence of any psychiatric disorders on structured psychiatric interview (DICA-IV).
Presence of known genetic conditions.
Presence or history of medical conditions.
Presence of metal objects, pregnancy, or inability to provide a specimen to rule out pregnancy in females over age 12.
Presence of alcohol and/or other substance abuse.
6 Years
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute of Mental Health (NIMH), 9000 Rockville Pike
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Brandt KR, Hattery RR. MRI during pregnancy. Eur Radiol. 1997;7(6):821. doi: 10.1007/s003300050213. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01-M-0064
Identifier Type: -
Identifier Source: secondary_id
010064
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.